Condition: Persistent Allergic Asthma
Interventions: Drug: Omalizumab; Drug: Placebo
Sponsors: Novartis; Genentech
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Breathe Well Live Well